🏆 Finalist — NIH Data Sharing Index (“S-Index”) Challenge

Philip Homan

National Cancer Institute

ORCID: 0000-0002-3389-4931
Biochemistry, Genetics and Molecular BiologyImmunology and MicrobiologyMedicine

Pilot corpus only

This score is computed over theSindex pilot corpus and does not cover the full scientific literature. Scores are relative to papers we have ingested — papers, authors, and institutions outside the pilot are not represented. Methodology.

Top 100%percentile
0Author DataRank

Indexed papers

0in pilot corpus
datarank_citation_only_1hop_v6· scope data_onlyMethodology

Papers

Driven by 10 papers. Top paper: “Phase I/II study of PexaVec in combination with immune checkpoint inhibition in refractory metastatic colorectal cancer”.

Phase I/II study of PexaVec in combination with immune checkpoint inhibition in refractory metastatic colorectal cancer

Journal for ImmunoTherapy of Cancer(2023)10.1136/jitc-2022-005640
N/A
1.4DataRank · unranked
72 citations

Changqing Xie, Yuta Myojin, Kelley Coffman, Donna Mabry Hrones, Sophie Wang +15 more

Rapid transient and longer-lasting innate cytokine changes associated with adaptive immunity after repeated SARS-CoV-2 BNT162b2 mRNA vaccinations

Frontiers in Immunology(2023)10.3389/fimmu.2023.1292568
N/A
0.733DataRank · unranked
24 citations

Evangelos Terpos, Philip Homan, Cristina Bergamaschi, Sevasti Karaliota, Ioannis Ntanasis‐Stathopoulos +9 more

Mechanistic analysis of Riboswitch Ligand interactions provides insights into pharmacological control over gene expression

Nature Communications(2024)10.1038/s41467-024-52235-3
N/A
0.439DataRank · unranked
9 citations

Desta Doro Bume, Colleen M. Connelly, Robert E. Boer, Peri R. Prestwood, Zhen Wang +8 more

Loss of Brca1 and Trp53 in adult mouse mammary ductal epithelium results in development of hormone receptor-positive or hormone receptor-negative tumors, depending on inactivation of Rb family proteins

Breast Cancer Research(2022)10.1186/s13058-022-01566-4
N/A
0DataRank · unranked
5 citations

Melanie B. Gordon, Lucy Lu, Nathan Pate, Laura Bassel, Anthony J. Iacovelli +9 more

Adoptive transfer of membrane-restricted IL-12-TCR T cells promotes antigen spreading and elimination of antigen-negative tumor variants

Journal for ImmunoTherapy of Cancer(2024)10.1136/jitc-2024-009868
N/A
0DataRank · unranked
3 citations

Scott M. Norberg, Farrah Karimipour, John Davies, А. С. Кузнецов, Wiem Lassoued +8 more

Cohesin Loading Factor NIPBL Is Essential for MYCN Expression and MYCN-Driven Oncogenic Transcription in Neuroblastoma

Cancers(2025)10.3390/cancers17162615
N/A
0DataRank · unranked
1 citations

Kaitlyn Tremble, Philip Homan, Carol J. Thiele, Jee-Youn Kang

Validating the fragment-based drug discovery strategy for targeting biological RNAs: Lead fragments specifically bind and remodel the TPP riboswitch

UNC Libraries(2020)10.17615/ace2-qp40
N/A
0DataRank · unranked
0 citations

Chris Abell, Kevin M. Weeks, Philip Homan, Alison G. Smith, K.D. Warner +1 more

Multimodal Approach for Identification and Validation of Hepatocellular Carcinoma Targets for Radiotheranostics

bioRxiv (Cold Spring Harbor Laboratory)(2025)10.1101/2025.11.21.689799
N/A
0DataRank · unranked
0 citations

Joon‐Yong Chung, Woong Hee Lee, Divya Nambiar, Julia Sheehan‐Klenk, Hima Makala +12 more

Characterization of HLH-like manifestations as a CRS variant in patients receiving CD22 CAR T cells

Blood(2021)10.1182/blood.2021011898
N/A
0DataRank · unranked
190 citations

Fiorella Schischlik, Lipei Shao, Seth M. Steinberg, Bonnie Yates, Hao‐Wei Wang +25 more

A chemical probe based on the PreQ1 metabolite enables transcriptome-wide mapping of binding sites

Nature Communications(2021)10.1038/s41467-021-25973-x
N/A
0DataRank · unranked
53 citations

Curran A. Rhodes, Desta Doro Bume, Colleen M. Connelly, Christopher C. Lai, James A. Kelley +6 more